LumiSTAR Biotechnology focuses on development of various drug screening platforms for pharmaceutical and CRO companies. We have been committed to accelerate drug development process. Our core technologies are various optical genetically-encoded reporters (with different detection dynamic ranges), which can be incorporated with iPSC or disease-model cell lines for real-time monitoring how the cellular physiology influenced by testing drugs. LumiSTAR’s drug screening platform can apply on phenotypic screening, drug discovery, toxicity testing, and precision/personalized medicine.
LumiSTAR's iPSC disease models:
Neurodegenerative Disease
Alzheimer's Disease
Parkinson's Disease
Cardiac Disease
Models for Toxicity Test
Issues on current drugs discovery & development
LumiSTAR's Technology
Applications
LumiSTAR is helping reduce the use of experimental animals
